Myelodysplastic syndromes /

Myelodysplastic syndromes / / edited by Ota Fuchs.

This book is a comprehensive overview of myelodysplastic syndromes (MDS). MDS are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, frequent karyotypic abnormalities, and risk of transformation to acute myeloid leukem...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Fuchs, Ota,
Place / Publishing House:Rijeka, Croatia : : IntechOpen,, [2016]
©2016
Year of Publication:2016
Language:English
Physical Description:1 online resource (210 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545555904498
ctrlnum (CKB)4970000000099139
(NjHacI)994970000000099139
(oapen)https://directory.doabooks.org/handle/20.500.12854/66902
(EXLCZ)994970000000099139
collection bib_alma
record_format marc
spelling Fuchs, Ota edt
Myelodysplastic syndromes / edited by Ota Fuchs.
IntechOpen 2016
Rijeka, Croatia : IntechOpen, [2016]
©2016
1 online resource (210 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022).
This book is a comprehensive overview of myelodysplastic syndromes (MDS). MDS are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, frequent karyotypic abnormalities, and risk of transformation to acute myeloid leukemia (AML). Median age of patients with MDS is about 70 years. Various immune abnormalities occur in MDS patients, and the relationship between autoimmune disorders and MDS is described. Accurate prognostication and risk stratification for individual patients with MDS are important for clinical treatment decisions. Patients with MDS are classified into two broad prognostic categories: lower risk and higher risk. The approval of lenalidomide, azacitidine, and decitabine in last 10 years helped to diminish the clinical impact of MDS and delayed its progression to AML.
English
Myelodysplastic syndromes.
Pathology
953-51-2586-9
Fuchs, Ota, editor.
language English
format eBook
author2 Fuchs, Ota,
author_facet Fuchs, Ota,
author2_variant o f of
o f of
author2_role TeilnehmendeR
title Myelodysplastic syndromes /
spellingShingle Myelodysplastic syndromes /
title_full Myelodysplastic syndromes / edited by Ota Fuchs.
title_fullStr Myelodysplastic syndromes / edited by Ota Fuchs.
title_full_unstemmed Myelodysplastic syndromes / edited by Ota Fuchs.
title_auth Myelodysplastic syndromes /
title_new Myelodysplastic syndromes /
title_sort myelodysplastic syndromes /
publisher IntechOpen
IntechOpen,
publishDate 2016
physical 1 online resource (210 pages)
isbn 953-51-7296-4
953-51-2587-7
953-51-2586-9
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC645
callnumber-sort RC 3645.73 M945 42016
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.41
dewey-sort 3616.41
dewey-raw 616.41
dewey-search 616.41
work_keys_str_mv AT fuchsota myelodysplasticsyndromes
status_str n
ids_txt_mv (CKB)4970000000099139
(NjHacI)994970000000099139
(oapen)https://directory.doabooks.org/handle/20.500.12854/66902
(EXLCZ)994970000000099139
carrierType_str_mv cr
is_hierarchy_title Myelodysplastic syndromes /
author2_original_writing_str_mv noLinkedField
_version_ 1787548708996382720
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00967nam a2200301 i 4500</leader><controlfield tag="001">993545555904498</controlfield><controlfield tag="005">20221017181556.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221017s2016 ci o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7296-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-2587-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000099139</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000099139</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66902</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000099139</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC645.73</subfield><subfield code="b">.M945 2016</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.41</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Fuchs, Ota</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Myelodysplastic syndromes /</subfield><subfield code="c">edited by Ota Fuchs.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2016</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2016]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (210 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This book is a comprehensive overview of myelodysplastic syndromes (MDS). MDS are a heterogeneous group of clonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, frequent karyotypic abnormalities, and risk of transformation to acute myeloid leukemia (AML). Median age of patients with MDS is about 70 years. Various immune abnormalities occur in MDS patients, and the relationship between autoimmune disorders and MDS is described. Accurate prognostication and risk stratification for individual patients with MDS are important for clinical treatment decisions. Patients with MDS are classified into two broad prognostic categories: lower risk and higher risk. The approval of lenalidomide, azacitidine, and decitabine in last 10 years helped to diminish the clinical impact of MDS and delayed its progression to AML.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Myelodysplastic syndromes.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Pathology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-2586-9</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Fuchs, Ota,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:23:35 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337979290004498&amp;Force_direct=true</subfield><subfield code="Z">5337979290004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337979290004498</subfield></datafield></record></collection>

Similar Items